Cybin

HELPNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$719.635 M

$11.61 +4.59%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#184Gyre TherapeuticsGYRE$743.6M
#185OculisOCS$735.2M
#186CybinHELP$719.6M
#187Evotec SEEVO$711.5M
#188Ironwood PharmaceuticalsIRWD$711.1M

Where these numbers come from

Share counts and financials for Cybin are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.